Studies show that more teens start using drugs during the summer months – while unsupervised and with more free time. With the end of the school year approaching, children look forward to a long break – and a lot of time at home alone. When teenagers are released from school for long break periods such [ Read More ]
The U.S. Food and Drug Administration approved Yervoy (ipilimumab) to treat patients with late-stage (metastatic) melanoma, the most dangerous type of skin cancer. Melanoma is the leading cause of death from skin disease. An estimated 68,130 new cases of melanoma were diagnosed in the United States during 2010 and about 8,700 people died from the [ Read More ]
The U.S. Food and Drug Administration approved Abstral (fentanyl) transmucosal tablets to manage breakthrough pain for adults with cancer. Fentanyl immediate-release transmucosal medications are administered on the soft surfaces of the mouth (inside of the cheek, gums, tongue), or the nasal passages or throat where they dissolve and are absorbed. “This is an important step [ Read More ]
Lisa Maas, executive director of Californians Allied for Patient Protection (CAPP), issued the following statement in response to a recent study published in the 2010 issue of Health Affairs which found that costs related to medical liability account for more than $55 billion a year or 2.4% of the total costs to the U.S. healthcare [ Read More ]
Fast Track status is granted to facilitate development and expedite the review of a drug for a serious or potentially fatal illness and to meet an unmet medical need. The Phase II trial for Progressive Supranuclear Palsy (PSP) commenced in December 2009 and is currently in progress. Belen Sopesen, CEO of Noscira: “Fast Track status [ Read More ]